Zevra Therapeutics
Zevra Therapeutics is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Zevra Therapeutics products.
Drugs from Zevra Therapeutics supported via NPP
| Brand | Generic | Category | Indication |
|---|---|---|---|
| Miplyffa | arimoclomol | Rare Disease (LSD) | Niemann-Pick disease type C (neurological manifestations) |
How NPP access to Zevra Therapeutics products works
Reserve Meds sources Zevra Therapeutics products from a US-licensed pharmaceutical wholesale partner, not from parallel-import channels. All supply is US-FDA-provenance.
Not affiliated with Zevra Therapeutics
Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Zevra Therapeutics.